PMID: 3763434Jul 1, 1986Paper

New evidence for neuronal function of vasopressin: sympathetic mediation of intrathecal vasopressin-induced hypertension

Peptides
D P Tan, K Tsou

Abstract

Intrathecal injection of arginine vasopressin in rats at a dose as small as 10 ng produced dose-dependent hypertension and tachycardia. Pretreatment with the ganglionic blocking agent Ecolid, alpha-adrenoceptor antagonist phenoxybenzamine or the monoamine depleting agent reserpine blocked this effect without affecting intravenous vasopressin-induced hypertension. Intracerebroventricular injection of arginine vasopressin also induced hypertension and tachycardia, but 600 ng was needed. Ecolid and phenoxybenzamine also abolished this effect. Reserpine was not tested. It is concluded that both intrathecal and intracerebroventricular vasopressin-induced hypertension appears to be mediated by the sympathetic system and that the spinal cord is more sensitive than the supraspinal sites to vasopressin in regulating autonomic functions.

Citations

Dec 3, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Britta Veitenheimer, John W Osborn
Jul 29, 2006·The Journal of Physiology·V R AntunesJ F R Paton
Feb 1, 1990·Hypertension·S Andreatta-Van LeyenC M Ferrario

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.